Dr. Douglas Rottmann is an Assistant Professor of Pathology at the University of Michigan Medical School, USA. He is widely recognized for his expertise in the field of pathology, particularly in the area of cancer diagnostics. His work focuses on enhancing diagnostic techniques and improving patient outcomes through more accurate and efficient cancer detection.
In addition to his academic role, Dr. Rottmann is deeply involved in cutting-edge research, contributing to advancements in cancer pathology and the development of novel diagnostic tools. His passion for improving clinical practice through research and his dedication to patient care have made him a respected and valued member of the oncology community.
Rania Bakkar
Dr. Rania Bakkar is a trailblazing Professor of Pathology at the City of Hope Comprehensive Cancer Center in Los Angeles, USA. Renowned for her expertise in cancer research, Dr. Bakkar has significantly advanced the understanding of cancer biology and innovative therapeutic strategies. Her work is focused on discovering new ways to improve treatment efficacy and patient outcomes in oncology.
With a commitment to improving cancer care through groundbreaking research, Dr. Bakkar has made significant contributions to the field. Her passion for advancing treatment options and her dedication to improving patient outcomes have established her as a leader in oncology, offering new hope to patients worldwide.
Kamran Mirza
Dr. Kamran Mirza holds a Ph.D. in Lung and Vascular Biology from the University of Illinois at Chicago and is an Associate Professor at Michigan Medicine. He is also a member of the Board of Directors for the American Society for Clinical Pathology (ASCP) in the USA.
With his extensive expertise in pathology and lung biology, Dr. Mirza is dedicated to bridging the gap between research and clinical practice. His innovative approach to cancer diagnostics and education has made a significant impact, inspiring the global medical community and advancing the field of oncology.
May Abdel-Wahab
Dr. May Abdel-Wahab is the Director of the Division of Human Health at the International Atomic Energy Agency (IAEA) in Vienna, Austria. She is an internationally recognized expert dedicated to advancing human health through cutting-edge research and innovation.
With her profound expertise and visionary leadership, Dr. Abdel-Wahab plays a pivotal role in fostering global collaboration in cancer care and treatment. Her work continues to address critical challenges in oncology, making her a key figure in the global effort to improve cancer outcomes and patient care.
Stephanie Skala
Dr. Skala is an expert in surgical pathology, with a strong dedication to advancing cancer diagnostics. She has made significant contributions to the understanding and early detection of complex cancers. Her work highlights the critical role of pathology in personalized cancer care, ultimately improving patient outcomes on a global scale.
Nagi Saghir
Professor Saghir is a renowned expert in breast cancer, committed to advancing both research and treatment in the field. His work has had a significant impact on the fight against cancer, positioning him as a leading figure in oncology.
Through his extensive contributions to breast cancer research and clinical care, Professor Saghir continues to shape the future of cancer treatment, improving outcomes for patients worldwide. His expertise and leadership have made him a respected authority in the oncology community.
Ellen Chapel
Ellen Chapel is a renowned Breast Pathologist who completed a prestigious fellowship in Breast Pathology at Brigham and Women’s Hospital in Boston. Currently practicing at the University of Michigan, USA, she is dedicated to advancing the field of breast pathology and improving patient outcomes. Her groundbreaking work and commitment to the field make her a valuable member of our speaker lineup.
Ulysses Balis
Professor Ulysses Balis is the Director of the Division of Pathology Informatics at the University of Michigan, USA. With a distinguished career in pathology informatics, he has been a pioneering figure in the integration of informatics with pathology to improve cancer diagnosis and treatment. His innovative research and leadership have helped shape the evolving landscape of cancer care, particularly in how technology and data-driven approaches can enhance patient outcomes.
Professor Balis’ contributions to the field have been instrumental in advancing the use of digital pathology, machine learning, and other informatics tools to better understand cancer. His work continues to inspire advancements in the integration of technology with clinical practice, making him a highly respected figure in both academic and medical communities.
Murat Gultekin
Dr. Gultekin is a renowned Gynecological Oncologist and a key opinion leader in the field of cancer care. He has made significant contributions to advancing the understanding and treatment of gynecological cancers, particularly in the areas of early detection and innovative therapeutic strategies. In addition to his clinical and research roles, he serves as a Government Official and Board Member of leading cancer organizations.
Dr. Gultekin is affiliated with the Turkish Ministry of Health and Hacettepe University in Türkiye, where he is deeply involved in shaping cancer policies and enhancing medical education. His expertise and leadership have made him an influential figure in the global oncology community, dedicated to improving outcomes for patients with gynecological cancers.
Abubakar Bello
Prof. Abubakar Bello is the President of AORTIC (African Organization for Research and Training in Cancer) and a prominent figure in the oncology community. He previously served as the Head of Radiotherapy and Oncology at the National Hospital in Abuja, Nigeria, where he made significant contributions to cancer treatment and care.
With decades of experience in the field, Prof. Bello is a passionate advocate for cancer research, education, and awareness across Africa. His leadership and dedication continue to drive efforts to improve cancer care and access to treatment across the continent.
Maia Dzhugashvili
Professor Maia Dzhugashvili is a distinguished Radiation Oncologist at the Madrid Oncology Institute in Spain. With a career focused on advancing cancer treatment, she has made notable contributions, particularly in the field of gynecological cancers. Her expertise and groundbreaking work have earned her international recognition as a leading figure in oncology.
Professor Dzhugashvili’s research and clinical practice continue to shape the future of cancer care, driving advancements in the treatment and management of gynecological malignancies. Her dedication to improving patient outcomes and advancing cancer treatment has made her a respected leader in the global oncology community.
